1.3240
-0.1000
(-7.02%)
At close: February 18 at 8:17:27 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-91,813.0000
-100,177.0000
-117,555.0000
-64,997.0000
-33,239.0000
Investing Cash Flow
--
370.0000
27.0000
-6.0000
-93.0000
Financing Cash Flow
101,767.0000
53,984.0000
200,712.0000
74,323.0000
44,722.0000
End Cash Position
38,830.0000
62,395.0000
108,245.0000
23,997.0000
14,548.0000
Issuance of Capital Stock
--
59,459.0000
228,945.0000
80,000.0000
49,758.0000
Free Cash Flow
-91,813.0000
-100,177.0000
-117,555.0000
-64,997.0000
-33,239.0000
12/31/2020 - 7/20/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6Y4.F Vicore Pharma Holding AB (publ)
0.7180
-1.37%
HQ1.MU Oruka Therapeutics Inc. R
10.80
0.00%
0WA2.IL Cellectis S.A.
1.5280
-0.65%
ICY.SG Incyte Corp
68.06
+1.49%
605116.SS Aurisco Pharmaceutical Co.,Ltd.
19.82
-0.60%
REGN.MX Regeneron Pharmaceuticals, Inc.
13,757.24
0.00%
22UA.DU BioNTech SE
115.60
+1.40%
PH4.F CStone Pharmaceuticals
0.3320
0.00%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3600
+0.56%
REGN34.SA Regeneron Pharmaceuticals, Inc.
64.71
0.00%